These studies reveal the multidimensional role of NSUN2 in tumor metabolic adaptation and malignant progression, suggesting that targeting NSUN2 and its downstream metabolic axes may provide novel combinatorial therapeutic strategies for various solid tumors and hematologic malignancies (Figure 3). The gene discussed is NSUN2; the disease is hematologic disorder.